semaglutide and fda Approves Oral as First GLP-1 Pill for Weight Loss UT San Antonio study: As

It is a GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptor agonist

ALCAR helps with Mild Cognitive Impairment (MCI) A gold-standard double-blind, randomized controlled trial on 1,204 people showed significant effect on attention, mental performance, memory and higher mental functions.[xii] In this study ALCAR seemed to ward off further brain deterioration

On February 21, 2025, the FDA updated its drug shortage list and labeled the shortage of all doses of injectable semaglutide as resolved

Our providers will work with you to determine the optimal treatment length for your desired outcomes, helping you plan for the financial aspect of your journey